Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Livanova Plc OR Sh (NQ: LIVN )

51.32 -0.38 (-0.74%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Livanova Plc OR Sh

< Previous 1 2 3 4 5 Next >
LivaNova Receives U.S. FDA 510(k) Clearance for Essenz Heart-Lung Machine for Cardiopulmonary Bypass Procedures
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Barclays Global Healthcare Conference
From LivaNova PLC
Via Business Wire
LivaNova Reports Fourth-Quarter and Full-Year 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova's Return on Invested Capital Overview
  
Via Benzinga
Recap: LivaNova Q2 Earnings
  LivaNova (NASDAQ:LIVN) reported its Q2 earnings results on Wednesday, August 3, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For February 22, 2023
Companies Reporting Before The Bell • Rio Tinto (NYSE:RIO) is projected to report earnings for its Fiscal Year 2022. 
Via Benzinga
Needham Remains Bullish On UK-Based MedTech Stock Citing Upcoming Catalyst
Via Benzinga
Analyst Ratings for LivaNova
Within the last quarter, LivaNova (NASDAQ:LIVN) has observed the following analyst ratings: 
Via Benzinga
LivaNova Initiates Limited Commercial Release in Europe of the Essenz Perfusion System for Cardiopulmonary Bypass Procedures
From LivaNova PLC
Via Business Wire
LivaNova Launches SenTiva DUO
From LivaNova PLC
Via Business Wire
LivaNova to Announce Fourth-Quarter and Full-Year 2022 Results
From LivaNova PLC
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For December 21, 2022
Via Benzinga
LivaNova Announces Receipt of Close-Out of Warning Letter from U.S. Food and Drug Administration
From LivaNova PLC
Via Business Wire
LivaNova to Present Scientific Data at American Epilepsy Society 2022 Annual Meeting
From LivaNova PLC
Via Business Wire
LivaNova Receives 510(k) Clearance for ECMO from FDA for LifeSPARC, the Next-generation Advanced Circulatory Support System
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Stifel, Wolfe and Piper Sandler Healthcare Conferences
From LivaNova PLC
Via Business Wire
LivaNova: Q3 Earnings Insights
LivaNova (NASDAQ:LIVN) reported its Q3 earnings results on Wednesday, November 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement. Earnings LivaNova beat estimated earnings... 
Via Benzinga
LivaNova Reports Third-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
Uber, Lyft, AZZ And Other Big Losers From Tuesday
U.S. stocks closed mixed with the Nasdaq Composite dropping more than 100 points on Tuesday. Here is the list of some big stocks recording losses in the previous session. 
Via Benzinga
LivaNova to Announce Third-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday
Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday. 
Via Benzinga
LivaNova Board Appoints Brooke Story as a New Director
From LivaNova PLC
Via Business Wire
Why ForgeRock Shares Are Trading Higher By Over 49%, Here Are 50 Stocks Moving In Tuesday's Mid-Day Session
Gainers FedNat Holding Company (NASDAQ: FNHC) shares jumped 140% to $0.3939. 
Via Benzinga
Catalent, Tellurian And Other Big Losers From Monday
U.S. stocks closed lower with the Dow Jones dropping around 185 points on Monday. Here is the list of some big stocks moving lower in the previous session. 
Via Benzinga
Why Bed Bath & Beyond Jumped Around 25%; Here Are 68 Biggest Movers From Yesterday
Gainers 
Via Benzinga
LivaNova Reports Second-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova to Announce Second-Quarter 2022 Results
From LivaNova PLC
Via Business Wire
LivaNova Elects Peter Wilver to Board of Directors
From LivaNova PLC
Via Business Wire
LivaNova to Present at the Goldman Sachs Global Healthcare Conference
From LivaNova PLC
Via Business Wire
Looking Into LivaNova's Return On Capital Employed
Pulled from Benzinga Pro data, LivaNova (NASDAQ:LIVN) posted Q1 earnings of $2.99 million, an increase from Q4 of 134.94%. Sales dropped to $240.20 million, a 11.07% decrease between quarters. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.